SRTS
Sensus Healthcare, Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
Sensus Healthcare (SRTS) Stock: Buy, Sell, or Hold?
$3.30
+0.12 (+3.77%)
▲
5d:
+0.46%
30d:
+12.63%
90d:
+5.43%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 12, 2026
TODAY
Protect SRTS Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (46%)
Quality Score
40/100
Position
EXTENDED
30-Day Fair Range
$2.75 – $3.07
Position: EXTENDED
Forward P/E & Valuation
-19.0x
CHEAP
vs 204.1x historical avg
Wall Street Target
$5.38
+62.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.71 / $5.25
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: SRTS shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When SRTS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SRTS is currently trading at $3.30, which is considered extended relative to its 30-day fair value range of $2.75 to $3.07. From a valuation perspective, the stock is trading at a discount (Forward PE: -19.0) compared to its historical average (204.1). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SRTS is showing sideways momentum. Immediate support is located at $2.71, while resistance sits at $5.25. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: SRTS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.38 (+62.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SRTS is showing sideways momentum. Immediate support is located at $2.71, while resistance sits at $5.25. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: SRTS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.38 (+62.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.75 -
$3.07
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
46.2%
Trading Range & Key Levels
30-Day Trading Range
$2.75 -
$3.07
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.44
(13.4%)
Support Level
$2.71
Resistance Level
$5.25
Current Trend
Sideways
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding SRTS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range (+7.5% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.8%)
- BULLISH: Trading 62.9% below Wall St target ($5.38)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-19.04
Wall Street Target
$5.38
(+62.9%)
Revenue Growth (YoY)
-68.7%
Earnings Growth (YoY)
433.3%
Profit Margin
-88.4%
PE vs Historical
-19.0 vs 204.1
CHEAP
Share SRTS Analysis
Share this live SRTS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SRTS)
Bearish
3 Retail Mentions
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Nov 3, 2026
Daily AI digest
AI Retail Discussion Summary:
Bearish sentiment prevails on StockTwits regarding $SRTS, with some traders expressing relief after closing short positions before a significant price drop.
Key Retail Themes:
short selling
price volatility
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:28 AM ET
Data refreshes hourly during market hours. Next update: 10:28 AM
Data refreshes hourly during market hours. Next update: 10:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRTS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 47 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 42 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 37 SELL |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 31 SELL |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
22 analysts |
$88 | 33 SELL |
Advanced SRTS Option Strategies
Professional options setups generated by AI based on today's SRTS price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SRTS Research Pages
